Actavis completes Forest Laboratories acquisition
MLex Summary: Generic drugmaker Actavis said Tuesday that the company has successfully completed its planned $25 billion cash-and-stock acquisition of drugmaker Forest Laboratories. Statement follows in full....To view the full article, register now.
Already a subscriber? Click here to view full article